Final results of the global and Asia cohorts of KAMILLA, a phase IIIB safety trial of trastuzumab emtansine in patients with HER2-positive advanced breast cancer
- Resource Type
- Article
- Source
- In
ESMO Open October 2022 7(5) - Subject
- Language
- ISSN
- 2059-7029